Pfizer and Moderna announced that their booster vaccines have been approved in the United States for everyone 18 years

Pfizer%20and%20Moderna%20announced%20that%20their%20booster%20vaccines%20have%20been%20approved%20in%20the%20United%20States%20for%20everyone%2018%20years
source: www.yahoo.com

Pfizer and Moderna announced that their booster vaccines have been approved in the United States for everyone 18 years of age and older.

Moderna CEO Stephane Bancel stated that the emergency use authorization "comes at a critical time as we enter the winter months and face a growing number of COVID-19 cases and hospitalizations."

The United States on Friday extended its support for the COVID-19 vaccine to all people over the age of 18, six months after completing their initial vaccination series, Multinational Laboratories Pfizer and Moderna announced. ۔

"This emergency use comes at a critical time as we enter the winter months and face an increasing number of COVID-19 cases and hospital admissions across the country, " said Moderna CEO Stephane Bancel.

Thus, the Government's campaign to strengthen protection is expanded and anticipates the increase in coronavirus cases that can worsen with the holidays. At least ten states had already started offering boosters to all adults.

" The decision helps to provide continued protection against COVID-19, including the serious consequences that can occur, such as hospitalization and death," said, for her part, the acting commissioner of the Food and Drug Administration (FDA, for its acronym in English), Janet Woodcock.

The FDA added that it based its decision on robust immune response data from hundreds of people who received the two vaccines.

The news came after Pfizer signed an agreement with the US government on Thursday to provide 10 million Paxlovid pills, which is still pending official authorization and aims to be the first oral treatment for patients with COVID-19 in the country.

The Government will pay Pfizer $ 5.29 billion for the ten million treatments once the Food and Drug Administration (FDA) endorses the emergency use of the drug, and delivery will begin later this year and continue throughout 2022.

The agreement signed with the Government was reached two weeks after Pfizer presented the pill results with 90% effectiveness for high-risk patients who accumulated three days of COVID-19 symptoms.

The agreed price considered the principles of " commitment, volume, equity, and affordability," the company said in a statement.

In parallel, Pfizer is negotiating bilaterally with regulatory agencies to conclude similar agreements with a hundred countries worldwide to distribute Paxlovid.

Pfizer is positioned as one of the pharmaceutical companies that has gone the furthest in the production of oral drugs against COVID-19, together with Merck, which launched Molnupiravir, approved for the moment in the United Kingdom at the beginning of November and with an ongoing negotiation with FDA.